BMY vs JNJ: Which Stock is Better?
Side-by-side comparison of Bristol-Myers Squibb Company and Johnson & Johnson in 2026
Comparison Updated:
BMY
Bristol-Myers Squibb Company
$55.77
JNJ
Johnson & Johnson
$209.72
Key Metrics Comparison
| Metric | BMY | JNJ | Winner |
|---|---|---|---|
| Market Cap | $113.72B | $492.44B | JNJ |
| P/E Ratio | 18.81 | 19.77 | BMY |
| EPS (TTM) | $2.97 | $10.34 | JNJ |
| Revenue Growth | 0.0% | 0.1% | JNJ |
| Gross Margin | 73.1% | 68.4% | BMY |
Analyze BMY
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BMY or JNJ a better investment?
Comparing BMY and JNJ: Bristol-Myers Squibb Company has a market cap of $113.72B while Johnson & Johnson has $492.44B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BMY and JNJ?
BMY (Bristol-Myers Squibb Company) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BMY or JNJ?
Based on P/E ratios, BMY trades at a lower multiple (18.8x vs 19.8x).